Monday, October 12, 2026

Salesforce Stock Bearish Momentum With A 8.98% Slide So Far Today

ViaNews Editorial Team

December 2, 2020

Salesforce Stock Bearish Momentum With A 8.98% Slide So Far Today

Even though Salesforce has been somewhat immune to the crisis, shares falling 8.98% to $219.68 at 14:09 EST on Wednesday, after two successive sessions in a row of losses. The New York Stock Exchange is jumping 0.1% to $14,161.00, following yesterday's upward trend, on what so far seems, a somewhat positive trend exchanging session today.

Salesforce's last close was $241.35, 29.51% under its 52-week high of $284.50.

News about Salesforce today

Salesforce confirms deal to buy slack. According to today's article on The Wall Street Journal, "The $27.7 billion purchase, which still has to clear Slack shareholder and regulatory approval, would be Salesforce’s largest ever acquisition and boost its competition with rival Microsoft.."

According to today's article on Bloomberg Quint, "Salesforce’s Benioff Escalates Microsoft Rivalry With Slack Deal."

Salesforce falls 7% after confirming $27.7 billion slack acquisition and forecasting slower growth. According to today's article on Business Insider, "<figure> <img alt="Salesforce Marc Benioff" class="img-responsive imported-news-entry-img" src="https://images2.markets.businessinsider.com/5fc78fc050e71a00115585a7?format=jpeg" /> <figcaption>Salesforce CEO Marc Benioff <p class="copyright">Business Insider<!-- sh_cad_1 --> </figcaption> </figure><ul><li><a href="https://markets.."

Stock alert: Salesforce tumbles 10%. According to today's article on Business Insider, "(RTTNews) - Shares of Salesforce.com, Inc."

Salesforce's Sales

Salesforce's sales growth is 13.8% for the present quarter and 16.6% for the next. The company's growth estimates for the current quarter and the next is 30.3% and 12.9%, respectively.

Salesforce's Revenue

Year-on-year quarterly revenue growth grew by 20.1%, now sitting on 20.29B for the twelve trailing months.

Salesforce's Stock Top and Bottom Yearly Value

Salesforce's stock is valued at $219.68 at 14:09 EST, way under its 52-week high of $284.50 and way above its 52-week low of $115.29.

Salesforce's Moving Average

Salesforce's value is way under its 50-day moving average of $251.35 and under its 200-day moving average of $220.48.

Previous days news about Salesforce

Salesforce to buy software maker slack for $27.7 billion. According to yesterday's article on Bloomberg Quint, "Salesforce agreed to buy Slack in one of the biggest technology deals of the year.."

According to yesterday's article on MarketWatch, "Salesforce to buy Slack in deal worth $27.7 billion."

Salesforce’s splashy slack deal isn't worth the risk. According to yesterday's article on Bloomberg Quint, "Salesforce’s Splashy Slack Deal Isn't Worth the Risk."

Salesforce plus slack doesn't equal Microsoft. According to yesterday's article on The Wall Street Journal, "Its $27.7 billion deal for Slack steps up Salesforce’s competition with Microsoft, but it might take even more acquisitions to gain ground.."

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic AI Rewires Enterprise Software: Platform Incumbents, Governance, and a Funded Startup Wave
Enterprise software is being rebuilt around autonomous AI agents. Incumbents and large platforms (SAP with its Autonomous Suite and Joule, Zeta with AthenaOS/AIM/Athena MCP, Meta with its new Enterprise Platform) are racing to own the agent layer. Meanwhile, seed and Series A money flows to finance-office and vertical startups (Dextr, Latitude, Dentira, Light), and consolidation continues through acquisitions (Tiny–Oso Cloud, Harvey–Guardrails AI). Investor commentary stresses that AI is better at disrupting around the edges of systems of record than at replacing them, that it should not be trusted with finance calculations, and that governance must be enforced by the system rather than left to agents.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,371 source documents archived
Query this data → isubstrate.com